Publicacións en colaboración con investigadores/as de Instituto de Parasitología y Biomedicina López Neyra (20)

2007

  1. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis

    Rheumatology, Vol. 46, Núm. 3, pp. 431-434

  2. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 287-293

  3. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132

  4. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 25, Núm. 1 SUPPL. 44

2006

  1. Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 1, pp. 83-86

  2. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura

    Journal of Rheumatology, Vol. 33, Núm. 1, pp. 69-73

  3. Cardiovascular disease in rheumatoid arthritis

    Biomedicine and Pharmacotherapy, Vol. 60, Núm. 10, pp. 673-677

  4. Giant cell arteritis and polymyalgia rheumatica: Pathophysiology and management

    Drugs and Aging, Vol. 23, Núm. 8, pp. 627-649

  5. Lack of Echocardiographic and Doppler Abnormalities in Psoriatic Arthritis Patients Without Clinically Evident Cardiovascular Disease or Classic Atherosclerosis Risk Factors

    Seminars in Arthritis and Rheumatism, Vol. 35, Núm. 5, pp. 333-339

  6. Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity [5]

    Annals of the Rheumatic Diseases

  7. Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 5, pp. 576-579

  8. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in Northwest Spain

    Journal of Rheumatology, Vol. 33, Núm. 2, pp. 285-288

  9. Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 3, pp. 309-312

  10. Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 33, Núm. 1, pp. 74-78

2005

  1. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 9, pp. 1737-1741

  2. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 11, pp. 2178-2182

  3. Giant cell arteritis: Laboratory tests at the time of diagnosis in a series of 240 patients

    Medicine, Vol. 84, Núm. 5, pp. 277-290

  4. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in Northwestern Spain

    Journal of Rheumatology, Vol. 32, Núm. 6, pp. 1081-1085

  5. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 32, Núm. 8, pp. 1510-1512

2004

  1. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain

    Rheumatology, Vol. 43, Núm. 9, pp. 1182-1185